BioCentury
ARTICLE | Clinical News

Remicade infliximab regulatory update

June 2, 2008 7:00 AM UTC

U.K.’s NICE issued a final appraisal recommending against the use of Remicade infliximab to treat severe ankylosing spondylitis. The agency concluded that the agent is not cost effective for the indic...